Dr. George E. Chaux, MD

Dr. Chaux practices at Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services.

Dr. Chaux's NPI, 1619938941, was assigned on March 28, 2006. Dr. Chaux graduated from Boston University School Of Medicine in 1990. Dr. Chaux holds California license G73323.

Dr. Chaux's primary practice is Providence Saint John's Health Center, at 2121 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5511.

Dr. Chaux's primary practice is Providence Saint John's Health Center in Santa Monica, California, part of Providence Health & Services. Dr. Chaux is also affiliated with Ronald Reagan UCLA Medical Center. Dmand AI also links Dr. Chaux to 2 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chaux practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Chaux's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Chaux is board certified in critical care medicine by the American Board of Internal Medicine. Dr. Chaux is licensed in California.

Dmand AI lists asthma, chronic obstructive pulmonary disease (COPD), chronic respiratory failure, lung resection, pneumonia, pneumonia and respiratory infection, pulmonary fibrosis and pulmonary heart disease among the conditions Dr. Chaux treats.

CMS data shows 1,593 Medicare services from Dr. Chaux across 19 procedure codes in 2024, for 448 Medicare patients. Medicare paid $149,905 for them.

CMS counts 448 Medicare patients who saw Dr. Chaux in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Chaux's median patient age at 73, with 60% women.

In 2024, Dr. Chaux wrote 290 Medicare Part D claims for 50 patients. 52% of them were for generic drugs. CMS names the drug for 125 of them, across 7 drugs with 11 or more claims each, at $443,080 in total drug cost. In 2023, CMS named 101 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Chaux for performance year 2024, reported as part of a group. Dr. Chaux accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Chaux as offering telehealth.

Dmand AI links 2 papers to Dr. Chaux, published from 2019 to 2021. Dr. Chaux's most frequent co-authors are Milan Jatin Anadkat, MD, Selim Mehmet Arcasoy, MD and David Alan Baran, MD.

Dmand AI links Dr. Chaux to 4 clinical trials. Conditions studied include Coronaviridae Infections, Pulmonary Arterial Hypertension and Coronavirus Infections.

CMS Open Payments shows 151 general payments to Dr. Chaux from 34 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 33% of the total. Pinnacle Biologics, Inc paid the most, $10,555.

Dr. Chaux graduated from Boston University School Of Medicine in 1990.

Dr. Chaux is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.